Research Papers

25 of 81 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Safety, biodistribution and radiation dosimetry of the Arg-Gly-Asp peptide 99m Tc-maraciclatide in healthy volunteers.
Gibbons T; Perkins A; Barnett J.
Nucl Med Commun (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Radioactive iodine therapy for follicular thyroid cancer: a 15 years follow-up study of Chinese patients.
Shi H; Yang B; Feng JI; Li JH; Cheng X; Li YJ; Fu Y; Xu XD; Qian LH; Tang LJ; Liu W.
Nucl Med Commun (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Radioactive iodine treatment for Graves' hyperthyroidism: incidence of Graves orbitopathy.
Quah NQX; Sobti MM; Wren AM; Scawn R; Kalogianni E; Cleland J; Maenhout A.
Nucl Med Commun (Unknown)
Published: 2023
2/6 Transparent
Nearly double the patients and dramatic changes over 14 years of UK MRT: Internal Dosimetry Users Group survey results …
Rojas B; McGowan DR; Gear J; Smith AL; Scott C; Craig AJ; Scuffham J; Towey D; Aldridge M; Tipping J.
Nucl Med Commun (Unknown)
Published: 2023
1/6 Transparent
BNMS UK PET standards.
Cook GJR; Dickson J; Chicklore S; Dempsey M; Ferreira A; MacKewn J; Meadows A; Testenera G; Wan S.
Nucl Med Commun (Unknown)
Published: 2023
2/6 Transparent
The tyrosine kinase inhibitor nintedanib enhances the efficacy of 90 Y-labeled B5209B radioimmunotherapy targeting ROBO…
Fujiwara K; Tsuji AB; Sudo H; Sugyo A; Hamakubo T; Higashi T.
Nucl Med Commun (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Rabbit systemic glucose metabolism map by total-body dynamic PET/CT technology.
Wang H; Xie X; Duan Y; Chai L; Li K; Qiu J; Cheng Z.
Nucl Med Commun (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Predictive value of SUVmax in visceral pleural invasive lung adenocarcinoma with different diameters.
Sun X; Chang C; Xie C; Zhu J; Ni X; Xie W; Wang Y.
Nucl Med Commun (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
18 F-FDG PET/CT for evaluation of metastases in nonsmall cell lung cancer on the efficacy of immunotherapy.
Feng Y; Wang P; Chen Y; Dai W.
Nucl Med Commun (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Clinical impact of molecular breast imaging as adjunct diagnostic modality in evaluation of indeterminate breast abnorm…
van Loevezijn AA; Corion CLS; Zeillemaker AM; Wijers LMH; Smithuis RHM; Valdés Olmos RA; van der Hage JA; de Geus-Oei LF; Benard M; Pereira Arias-Bouda LM.
Nucl Med Commun (Unknown)
Published: 2023
2/6 Transparent
Role of 18F-fluorodeoxyglucose PET/computed tomography in the diagnosis and treatment response assessment of primary bo…
Pu Y; Wang C; Xie R; Zhao S; Li K; Yang C; Li J; Xiang A; Wang Y; Chen L; Sun H.
Nucl Med Commun (Unknown)
Published: 2023
2/6 Transparent
Kidney absorbed radiation doses for [ 177 Lu]Lu-PSMA-617 and [ 177 Lu]Lu-PSMA-I&T determined by 3D clinical dosimetry.
Uijen MJM; Privé BM; van Herpen CML; Westdorp H; van Gemert WA; de Bakker M; Gotthardt M; Konijnenberg MW; Peters SMB; Nagarajah J.
Nucl Med Commun (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Current status of nuclear cardiology practice in Latin America and the Caribbean, in the era of multimodality cardiac i…
Peix A; Mesquita CT; Gutiérrez C; Puente A; Dueñas-C KA; Massardo T; Berrocal I; Astesiano A; Agüero RN; Bañolas R; Hiplan E; Sánchez M; Barreda AM; Gómez VV; Fernández C; Portillo S; Herrera Y; Mendoza A; Kapitan M; Castellanos C; Rodríguez DI; Estrada E; Páez D.
Nucl Med Commun (Unknown)
Published: 2022
2/6 Transparent
The value of the SUV ratio between lymph node and bone marrow in predicting pelvic lymphatic metastasis of patients wit…
Liu Y; Hua J; Liu L; Zhang W; Xu S; Chen X.
Nucl Med Commun (Unknown)
Published: 2022
2/6 Transparent
Preliminary evaluation of a small interfering RNA molecular probe targeting murine double minute 2 in breast cancer.
Wang X; Xu P; Jiao Y; Luan S; Gao Y; Zhao C; Fu P.
Nucl Med Commun (Unknown)
Published: 2022
4/6 Transparent
Data Funding Declared
Anatomical breast imaging-derived parameters do not provide incremental information in prediction of nonvisualization o…
Chahid Y; Verberne HJ; Poel E; Hendrikse NH; Booij J.
Nucl Med Commun (Unknown)
Published: 2022
2/6 Transparent
Prognostic value of node-to-primary tumor maximum standardized uptake value ratio in T1-4N1-3M0 non-small cell lung can…
Li TC; Zhao X; Liu YN; Wang GL; Liu KF; Zhao K.
Nucl Med Commun (Unknown)
Published: 2022
2/6 Transparent
18F-FDG-PET/MRI texture analysis in rectal cancer after neoadjuvant chemoradiotherapy.
Capelli G; Campi C; Bao QR; Morra F; Lacognata C; Zucchetta P; Cecchin D; Pucciarelli S; Spolverato G; Crimì F.
Nucl Med Commun (Unknown)
Published: 2022
2/6 Transparent
Biodistribution of 89Zr-oxine-labeled human bone marrow-derived mesenchymal stem cells by micro-PET/computed tomography…
Wang S; Wang Y; Xu B; Qin T; Lv Y; Yan H; Shao Y; Fang Y; Zheng S; Qiu Y.
Nucl Med Commun (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Test-retest repeatability and interobserver variation of healthy tissue metabolism using 18F-FDG PET/CT of the thorax a…
Malaih AA; Dunn JT; Nygård L; Kovacs DG; Andersen FL; Barrington SF; Fischer BM.
Nucl Med Commun (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
[18F]FDG PET/MRI in the follow-up of hepatocellular carcinoma after liver transplantation.
Zucchetta P; Lacognata C; Girardi F; Spimpolo A; Crimì F; Cabrelle G; Zanon C; Boccagni P; Evangelista L; Cecchin D; Cillo U.
Nucl Med Commun (Unknown)
Published: 2022
2/6 Transparent
Effect of Bayesian penalty likelihood algorithm on 18F-FDG PET/CT image of lymphoma.
Wang Y; Lin L; Quan W; Li J; Li W.
Nucl Med Commun (Unknown)
Published: 2022
2/6 Transparent
Postoperative radioiodine therapy impact on survival in poorly differentiated thyroid carcinoma: a population-based stu…
Xu L; Zou Q; Jiao J; Zhang Y.
Nucl Med Commun (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Impact of 18F-fluciclovine PET/CT on salvage radiotherapy plans for men with recurrence of prostate cancer postradical …
Payne H; Bomanji J; Bottomley D; Scarsbrook AF; Teoh EJ; FALCON study group.
Nucl Med Commun (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Site-based performance of 131I-MIBG imaging and 99mTc-HYNIC-TOC scintigraphy in the detection of nonmetastatic extra-ad…
Hou G; Jiang Y; Li F; Zhu Z; Jing H.
Nucl Med Commun (Unknown)
Published: 2022
3/6 Transparent
Funding Declared